AUG 08, 2018 5:50 AM PDT

Injection Improves Corneal Transplant Outcomes

WRITTEN BY: Nouran Amin

The common form of tissue transplant is the corneal transplant. Corneal transplantation is performed to correct visual loss that has occurred when the cornea, the transparent structure forming the front of the eye, becomes opaque (cloudy) as a result of many eye diseases.

According to a research study in the American Journal of Pathology, Injection of neuropeptide vasoactive intestinal peptide (VIP) directly into the eye of mouse models was found to enhance corneal graft survival. The injection was also found to produce other benefits such as accelerating wound healing, protecting corneal endothelial cells, and improving the corneal graft clarity. If VIP is shown successfully in clinical studies, the novel approach may bring hope to patients who lost their vision due to corneal disease. "The successful outcome of corneal transplantation mainly relies on the density and function of CEnCs, which keep the graft transparent. To improve the outcomes of corneal transplantation, various strategies have been employed to prevent immune-mediated graft rejection or enhance survival and function of CEnCs. However, an effective method has remained elusive so far," explains Dr. Ahmad Kheirkhah of the University of Texas San Antonio. During the study, researchers evaluated the effect of VIP on corneal tissue in cell culture and living animals who received corneal transplants.

VIP is a 28-amino acid neuropeptide found in the aqueous humor of the eye and may be secreted by corneal endothelial cells. It is recognized as a protection and immunoregulation factor in multiple organ systems. In mice that underwent corneal transplantation, grafts were more transparent in VIP-treated mice comparison to the controls. After eight weeks since transplantation, 85 percent of VIP-treated grafts have survived in comparison to only 0 percent of control grafts. Additionally, corneal endothelial cell density was higher in VIP-treated corneas than controls. "Millions of patients around the world are blind due to corneal opacity, and they are in dire need of corneal transplantation. Unfortunately, there is a significant shortage of donor corneas across the world. On the other hand, many donated corneas cannot be used for transplantation due to inadequate endothelial cells. Moreover, corneal transplants can deteriorate over time due to continuous loss of CEnCs," noted Reza Dana, MD, MPH, MSc, Professor of Ophthalmology at the Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. "If confirmed in further clinical studies, we believe that the use of VIP will increase the number of donated corneas suitable for transplantation and improve the outcomes of corneal transplantation."

 

Source: Elsevier

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 08, 2020
Neuroscience
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
NOV 08, 2020
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
Researchers from the F.M. Kirby Neurobiology Center in the US have discovered a new approach to restore myelin sheaths, ...
NOV 20, 2020
Drug Discovery & Development
Hyperbaric Oxygen Treatments Reverse Aging
NOV 20, 2020
Hyperbaric Oxygen Treatments Reverse Aging
Researchers from Israel have found that hyperbaric oxygen treatments (HBOT) in healthy aging adults can prevent blood ce ...
DEC 15, 2020
Cannabis Sciences
Could Cannabis Help in the Opioid Crisis?
DEC 15, 2020
Could Cannabis Help in the Opioid Crisis?
While cannabis is increasingly available for medicinal use, doctors largely remain unable to prescribe it to their patie ...
DEC 15, 2020
Drug Discovery & Development
Drug Reverses Age-Related Mental Decline
DEC 15, 2020
Drug Reverses Age-Related Mental Decline
An experimental drug, called ISRIB, has shown to reverse age-related mental decline in mice with just a few doses " ...
DEC 30, 2020
Cannabis Sciences
Cannabis Reduces Stress and Anxiety in Over 95% of Cases
DEC 30, 2020
Cannabis Reduces Stress and Anxiety in Over 95% of Cases
Whether cannabis will induce feelings of relaxation or anxiety often feels like a coin toss. Now, however, researchers f ...
JAN 05, 2021
Neuroscience
Synthetic Psychedelic Treats Depression Without Hallucinations
JAN 05, 2021
Synthetic Psychedelic Treats Depression Without Hallucinations
Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to ...
Loading Comments...